These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Role of cytogenetic studies in ophthalmology and pediatric oncology]. Pogosiants EE; Kuznetsova LE Oftalmol Zh; 1983; 38(5):310-3. PubMed ID: 6358982 [No Abstract] [Full Text] [Related]
9. Personalized ocular oncology care: how far have we come? Jager MJ Can J Ophthalmol; 2024 Oct; 59(5):e423-e424. PubMed ID: 38810956 [No Abstract] [Full Text] [Related]
10. Referral patterns of intraocular tumour patients to a dedicated Canadian ocular oncology department. Law C; Krema H; Simpson ER Can J Ophthalmol; 2012 Jun; 47(3):254-61. PubMed ID: 22687302 [TBL] [Abstract][Full Text] [Related]
11. Personalized medicine in ocular oncology: a brighter future for eye cancer care. Dalvin LA Can J Ophthalmol; 2024 Aug; 59(4):e299-e300. PubMed ID: 38228284 [No Abstract] [Full Text] [Related]
12. [Seventy years of development and prospects of the ocular oncology specialty in China]. Fan XQ; Jia RB Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):646-652. PubMed ID: 32907298 [TBL] [Abstract][Full Text] [Related]